YGR161W-C Antibody

Shipped with Ice Packs
In Stock

Description

Search Results Analysis

The provided search results cover:

  • General antibody structure and function (NCBI Bookshelf , Abcam )

  • Specific antibody classes (IgM anti-c case study )

  • Antibody characterization challenges (eLife )

  • Structural dynamics of immunoglobulins (PMC )

  • Approved therapeutic antibodies (Antibody Society )

None of these sources mention "YGR161W-C Antibody" or any related nomenclature.

Nomenclature Issues

  • The identifier "YGR161W-C" does not align with standard antibody naming conventions (e.g., INN/USAN, IgG subclass, or target-specific formats like anti-PD-1).

  • Yeast genome nomenclature uses "YGR161W" to denote chromosomal coordinates for genes, but this does not correspond to antibody terminology.

Research Status

  • No clinical or preclinical studies referencing this compound appear in PubMed, clinical trial registries, or industry databases.

  • The Antibody Society’s therapeutic antibody database ( ) lists ~200 approved/reviewed antibodies (e.g., Retifanlimab, Regdanvimab) but does not include this entity.

Recommendations for Further Investigation

StepActionPurpose
1Verify nomenclatureConfirm if "YGR161W-C" refers to a gene product, hypothetical antibody, or typographical error.
2Consult specialized databasesSearch the Universal Protein Resource (UniProt), DrugBank, or Patent Commons for unpublished data.
3Contact developersReach out to academic/commercial entities listed in antibody catalogs (e.g., Abcam, Thermo Fisher).

Limitations of Current Data

  • Antibody characterization crisis: ~50% of commercial antibodies lack sufficient validation ( ), so unverified reagents may exist without published profiles.

  • Therapeutic antibodies: Novel candidates in early development (e.g., Nemolizumab ) may not yet be publicly documented.

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YGR161W-C antibody; Uncharacterized protein YGR161W-C antibody
Target Names
YGR161W-C
Uniprot No.

Q&A

What is YGR161W-C and why is it significant in genomic research?

YGR161W-C (also annotated as RTS3/YGR161W-C in some databases) represents a yeast gene encoding a protein involved in DNA-binding functions . The significance of YGR161W-C lies in its potential role in transcriptional regulation networks. Based on genomic studies, this protein appears in experimental contexts where researchers investigate protein-DNA interactions, particularly in techniques designed to identify binding sites of transcription factors. Understanding YGR161W-C is valuable for researchers studying fundamental aspects of gene regulation and chromatin interactions in yeast models, which often translate to insights applicable to higher eukaryotes.

What experimental methods are most appropriate for detecting YGR161W-C binding sites in the genome?

Several experimental approaches can effectively detect YGR161W-C binding sites:

  • Chromatin Immunoprecipitation (ChIP-chip): This method allows identification of binding sites by using YGR161W-C antibodies to immunoprecipitate the protein along with its bound DNA fragments, which are then hybridized to microarrays . This technique provides genome-wide binding profiles and has been successfully applied to similar transcription factors.

  • Ty5 Transposon "Calling Cards" Method: A novel approach described in the literature where DNA-binding proteins fused with Sir4 direct the insertion of the Ty5 retrovirus-like transposon near their binding sites. The genomic locations of these insertions can then be mapped to identify binding sites . This method has successfully identified targets of well-characterized transcription factors like Gal4 and Gcn4.

  • Yeast One-Hybrid Screens: Particularly useful when starting with a DNA sequence of interest and seeking to identify proteins (potentially including YGR161W-C) that bind to it .

Each method offers distinct advantages depending on experimental priorities (genome-wide coverage versus focused analysis of specific regions).

How can I verify the specificity of a YGR161W-C antibody for immunoprecipitation experiments?

Verifying antibody specificity is critical for reliable results in immunoprecipitation experiments. For YGR161W-C antibodies, consider these validation approaches:

  • Western blot with positive and negative controls: Test the antibody against samples with known expression levels of YGR161W-C, including wild-type strains and YGR161W-C deletion mutants.

  • Epitope-tagged validation: Compare immunoprecipitation results between native YGR161W-C and an epitope-tagged version (e.g., myc-tagged YGR161W-C) using both the YGR161W-C antibody and a commercial anti-tag antibody . Correlation between results supports antibody specificity.

  • Competitive blocking: Pre-incubate the antibody with purified YGR161W-C protein before immunoprecipitation. Reduced signal indicates specific binding.

  • Sequential ChIP experiments: Perform ChIP with the YGR161W-C antibody followed by another ChIP with a different antibody targeting a known interaction partner to confirm co-localization at genuine binding sites.

Document these validation steps thoroughly, as they will strengthen the credibility of subsequent experimental findings.

How can I resolve contradictory results between ChIP-chip and Calling Card methods when studying YGR161W-C binding sites?

Contradictory results between different methods for identifying YGR161W-C binding sites can provide valuable insights rather than merely representing experimental error. Consider this structured approach to resolve discrepancies:

  • Examine methodological biases:

    • ChIP-chip may be biased toward stronger or more stable binding interactions

    • The Calling Cards method might favor binding sites that are more accessible to the transposition machinery

  • Cross-validation analysis:

    • Focus on sites identified by both methods as high-confidence targets

    • For sites identified by only one method, perform directed validation using an orthogonal approach such as EMSA or DNase I footprinting

  • Biological context consideration:

    • Analyze discrepancies in light of chromatin state data

    • Consider if differences correlate with specific functional categories of genes

    • Examine temporal aspects of binding (constitutive vs. condition-specific)

  • Statistical refinement:

    • Adjust significance thresholds based on known false positive/negative rates

    • The Calling Cards method has shown approximately 49% false negative frequency at a 2.5% false positive rate, compared to ChIP-chip's 25% false negative frequency at a 1% false positive rate

Contradictions often emerge from the complementary strengths and limitations of different methods, collectively providing a more complete picture of the biological reality.

What strategies can improve the sensitivity and specificity when using YGR161W-C antibodies for chromatin studies?

Enhancing sensitivity and specificity in YGR161W-C chromatin studies requires optimization at multiple levels:

  • Crosslinking optimization:

    • Test multiple formaldehyde concentrations (0.5-3%)

    • Explore dual crosslinking with both formaldehyde and protein-specific crosslinkers

    • Optimize crosslinking time to maximize signal while minimizing artifacts

  • Antibody selection and handling:

    • Use polyclonal antibodies for initial discovery and monoclonal antibodies for targeted validation

    • Test multiple antibodies targeting different epitopes of YGR161W-C

    • Employ stringent pre-clearing steps to remove non-specific interactions

  • Chromatin preparation refinements:

    • Optimize sonication conditions to achieve consistent fragment sizes (200-500bp)

    • Implement two-step chromatin shearing (enzymatic followed by sonication)

    • Use density gradient centrifugation to enrich for chromatin fractions

  • Controls and normalization:

    • Include input controls, IgG controls, and technical replicates

    • Implement spike-in normalization with exogenous chromatin

    • Use known binding regions as internal controls for experimental validation

  • Data analysis enhancements:

    • Apply multiple peak-calling algorithms and focus on consensus peaks

    • Implement batch correction for multi-sample experiments

    • Utilize machine learning approaches to distinguish true binding events from background

These strategies collectively address the major sources of variability in chromatin immunoprecipitation experiments and can significantly improve data quality.

How can I design experiments to identify proteins that interact with YGR161W-C at specific genomic loci?

Identifying proteins that interact with YGR161W-C at specific genomic regions requires sophisticated experimental approaches that combine protein interaction discovery with genomic localization:

  • Proximity-based labeling coupled with ChIP:

    • Express YGR161W-C fused to a proximity labeling enzyme (BioID or APEX2)

    • After activation, biotinylated proteins can be purified and identified by mass spectrometry

    • Follow with ChIP to confirm co-localization at specific genomic sites

  • Modified Calling Cards approach with dual tagging:

    • Develop a system where both YGR161W-C and potential interacting proteins are fused to complementary parts of the Sir4-Ty5 system

    • Interaction between proteins would lead to enhanced Ty5 integration near specific binding sites

    • Barcode analysis can identify which protein combinations interact at which genomic locations

  • Sequential ChIP (Re-ChIP):

    • Perform initial ChIP with YGR161W-C antibody

    • Re-immunoprecipitate using antibodies against suspected interaction partners

    • Analyze enriched regions to identify co-occupancy sites

  • Protein complex purification from specific genomic regions:

    • Adapt techniques like PICh (Proteomics of Isolated Chromatin segments) to isolate specific YGR161W-C-bound genomic regions

    • Identify co-purifying proteins by mass spectrometry

The table below compares these approaches across key parameters:

MethodSpatial ResolutionDiscovery PotentialTechnical DifficultyIn vivo Relevance
Proximity Labeling + ChIPMediumHighMediumHigh
Modified Calling CardsHighMediumHighHigh
Sequential ChIPMediumLowMediumVery High
PIChVery HighHighVery HighHigh

Selection of the appropriate method should be guided by the specific research question and available resources.

What statistical approaches are most appropriate for analyzing YGR161W-C binding site data?

Statistical analysis of YGR161W-C binding site data requires consideration of both the biological context and technical aspects of the experimental methods used:

  • Peak calling optimization:

    • For ChIP-chip data, algorithms like MAT or TileMap with appropriate FDR thresholds

    • For Calling Cards data, develop custom analysis pipelines that account for transposition biases

    • Compare multiple algorithms and focus on consensus results

  • Significance assessment:

    • Implement appropriate multiple testing correction (Benjamini-Hochberg or Bonferroni)

    • Calculate false discovery rates based on control experiments

    • For Calling Cards method, be aware that approximately 49% false negative frequency at a 2.5% false positive rate has been observed in similar experiments with other transcription factors

  • Signal normalization strategies:

    • Normalize to input DNA and IgG controls

    • Apply quantile normalization for microarray data

    • Consider spike-in normalization for cross-sample comparisons

  • Integrative analysis:

    • Correlate binding data with expression profiles

    • Integrate with nucleosome positioning and histone modification data

    • Apply machine learning approaches to identify combinatorial binding patterns

When analyzing Calling Cards data specifically, be attentive to potential recombination events with endogenous Ty5 elements that can create false positives, particularly near telomeric regions .

How can I distinguish between direct and indirect YGR161W-C DNA binding events in genomic data?

Distinguishing direct from indirect DNA binding is crucial for accurately mapping transcription factor networks. For YGR161W-C, consider these approaches:

  • Motif analysis and validation:

    • Perform de novo motif discovery on YGR161W-C binding sites

    • Test direct binding to identified motifs using in vitro methods like EMSA

    • Compare binding strength at sites with and without the consensus motif

  • Structural considerations:

    • Analyze binding sites in the context of DNA shape and flexibility

    • Examine nucleosome positioning at binding sites (direct binding often occurs in nucleosome-free regions)

  • Experimental validation strategies:

    • Perform DNase I footprinting to identify precise binding locations

    • Use mutations in candidate motifs to assess their requirement for binding

    • Apply high-resolution techniques like ExoIII footprinting or ChIP-exo

  • Integrative genomic analysis:

    • Compare YGR161W-C binding with binding patterns of known co-factors

    • Sites bound by YGR161W-C alone are more likely to represent direct binding

    • Indirect binding sites often show complex occupancy patterns involving multiple factors

  • Protein domain mutations:

    • Engineer mutations in the DNA-binding domain of YGR161W-C

    • Compare binding profiles between wild-type and mutant proteins

    • Loss of binding at direct targets without affecting indirect targets

These approaches should be used in combination to build confidence in the classification of binding sites as direct or indirect.

How can YGR161W-C antibodies be applied in studies of transcriptional regulatory networks in yeast?

YGR161W-C antibodies can serve as powerful tools in dissecting transcriptional regulatory networks through several sophisticated applications:

  • Temporal network mapping:

    • Use time-course ChIP experiments with YGR161W-C antibodies to capture dynamic binding changes during cellular responses

    • Correlate with expression data to identify direct regulatory relationships

    • Apply mathematical modeling to infer network dynamics and feedbacks

  • Perturbation-based network analysis:

    • Combine YGR161W-C binding data with systematic genetic perturbations

    • Use antibodies to track binding site redistributions after deleting specific network components

    • Identify condition-specific regulatory modules and their hierarchical organization

  • Multi-factor binding analysis:

    • Implement the Calling Cards method with molecular barcoding for multiple transcription factors including YGR161W-C

    • Identify combinatorial binding patterns and cooperative/competitive relationships

    • Create comprehensive maps of transcription factor co-occupancy

  • Cross-species network conservation:

    • Apply YGR161W-C antibodies in comparative studies across yeast species

    • Identify evolutionarily conserved and divergent binding sites

    • Trace the evolution of regulatory networks involving YGR161W-C

This approach has already shown success with other transcription factors like Gal4 and Gcn4, where researchers discovered previously unidentified targets through methodologies like the Calling Cards technique .

What emerging technologies might enhance the study of YGR161W-C function beyond traditional antibody applications?

The future of YGR161W-C research will likely be transformed by emerging technologies that complement or even replace traditional antibody-based approaches:

  • CRISPR-based genomic targeting:

    • CUT&RUN or CUT&Tag approaches using catalytically inactive Cas9 fused to YGR161W-C

    • Higher resolution mapping with reduced background compared to conventional ChIP

    • More efficient use of biological material with single-cell potential

  • Single-molecule tracking:

    • Live-cell imaging of fluorescently-tagged YGR161W-C to observe binding dynamics

    • Super-resolution microscopy to visualize the spatial organization of binding events

    • Correlation with chromatin accessibility in real-time

  • Protein-DNA interaction mapping in situ:

    • Techniques like FLASH that preserve nuclear architecture while mapping interactions

    • Integration with chromosome conformation capture methods (Hi-C) to understand 3D context

    • Multi-modal approaches connecting binding events with nuclear compartmentalization

  • Next-generation Calling Cards approaches:

    • Development of mammalian-compatible Calling Cards systems based on the yeast model

    • Higher-throughput approaches that capture thousands more transposition events

    • Integration of barcode sequencing with single-cell technologies for cell-type-specific mapping

  • Computational advancements:

    • Deep learning models trained on YGR161W-C binding data to predict binding in novel contexts

    • Integration of multi-omics data to build comprehensive regulatory models

    • Simulation of binding dynamics incorporating biophysical parameters

These emerging technologies will expand our understanding of YGR161W-C beyond simple binding site identification toward a dynamic, context-dependent view of its function.

What are the most significant unanswered questions regarding YGR161W-C function in yeast gene regulation?

Despite advances in studying DNA-binding proteins like YGR161W-C, several fundamental questions remain unanswered:

  • Condition-specific binding dynamics: How does YGR161W-C binding change across different stress conditions or developmental stages? The transient nature of certain regulatory interactions makes them difficult to capture with static methods.

  • Combinatorial regulatory logic: How does YGR161W-C function in concert with other transcription factors to achieve specific regulatory outcomes? The syntax of this combinatorial control remains poorly understood.

  • Mechanistic details of regulation: Does YGR161W-C primarily function as an activator, repressor, or both depending on context? What cofactors are required for its various functions?

  • Evolutionary conservation of function: To what extent are YGR161W-C binding sites and regulatory roles conserved across fungal species, and what does this reveal about core regulatory networks?

  • Non-canonical functions: Does YGR161W-C participate in processes beyond transcriptional regulation, such as chromosome organization or DNA repair?

These questions represent fruitful directions for researchers applying techniques like the Calling Cards method or ChIP-chip approaches to study YGR161W-C's role in genomic regulation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.